InsideArbitrage Event Driven Monitor – August 18, 2023
Subscribe to receive our Event Driven Monitor by email every morning before the market opens.
Merger Arbitrage
- CELL: PhenomeX to be acquired by Bruker Corporation (BRKR) for $40.14 million or $1 per share in cash.
- FRG: Franchise Group (FRG) announced that its stockholders approved all proposals related to the proposed acquisition of the company.
- PRDS: Pardes Biosciences and MediPacific determined that the Additional Price Per Share, based on Pardes’ expected net cash, is $0.11 per share. Accordingly, the total cash amount that Purchaser will pay pursuant to the terms of the Offer and the Merger Agreement is $2.13 per share. MediPacific also extended the Offer’s expiration date to August 30, 2023.
Only plus or premium subscribers can access this post. Subscribe today.
